Astellas Pharma Inc. - Diluted EPS

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY.

The item "Diluted-EPS" stands at 69.44 Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 03/31/2021.

Astellas Pharma Inc.'s second quarter result of 44.06 JPY for the item "Diluted EPS" represents an increase of 15.62 percent compared to it's first quarter result.

Also, Astellas Pharma Inc.'s second quarter result of 44.06 JPY for the item "Diluted EPS" represents an increase of 121.03 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s second quarter result of 69.44 JPY for the item "Diluted EPS" represents an increase of 53.24 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 38.72 Japanese Yens compared to the value the year prior.
The 1 year change is 38.72 Japanese Yens.
The 3 year change is 1.13 Japanese Yens.
The 5 year change is -5.40 Japanese Yens.
The 10 year change is -7.63 Japanese Yens.

The Serie's long term average value is 63.00 Japanese Yens. It's latest available value, on 09/30/2025, is 6.44 Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is +101.34 .
The Serie's change in Japanese Yens from it's maximum value, on 09/30/2019, to it's latest available value, on 09/30/2025, is -60.25 .